Histogen Inc (HSTO)
0.35
0.00 (0.00%)
USD |
OTCM |
Apr 23, 16:00
Histogen Free Cash Flow (Quarterly): -2.689M for Sept. 30, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -2.689M |
| June 30, 2023 | -2.396M |
| March 31, 2023 | -2.55M |
| December 31, 2022 | -2.44M |
| September 30, 2022 | -2.459M |
| June 30, 2022 | -4.64M |
| March 31, 2022 | -0.36M |
| December 31, 2021 | -2.868M |
| Date | Value |
|---|---|
| September 30, 2021 | -3.933M |
| June 30, 2021 | -4.36M |
| March 31, 2021 | -3.612M |
| December 31, 2020 | -4.074M |
| September 30, 2020 | -3.75M |
| June 30, 2020 | -3.374M |
| March 31, 2020 | -0.905M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-4.64M
Minimum
Jun 2022
-0.36M
Maximum
Mar 2022
-2.961M
Average
-2.868M
Median
Dec 2021
Free Cash Flow (Quarterly) Benchmarks
| CEL-SCI Corp | -4.953M |
| AIM ImmunoTech Inc | -9.956M |
| IGC Pharma Inc | -1.674M |
| NovaBay Pharmaceuticals Inc | -0.316M |
| Protalix BioTherapeutics Inc | 3.345M |